WaveMan · Form 4
Soni Manmeet Singh insider trades
> Search tickers & screens ⌘K
LIVE

Soni Manmeet Singh insider trades

Soni Manmeet Singh has filed 28 Form 4s with the SEC that we hold, for RETA (COO, CFO and President), Summit Therapeutics Inc. (SMMT) (COO and CFO, Director) and Pulse Biosciences, INC. (PLSE) (Director). Across all of them we count 4 purchases worth $6.1M and 16 sales worth $23.4M reported on Form 4. In the last 12 months: 2 purchases ($722.2K) and 0 sales ($0). The largest single trade was a sale of 75,000 shares of RETA worth $12.3M, dated 2023-07-28. The first filing on our record is dated 2022-01-04 and the latest 2026-06-15.

RETA

COO, CFO and President · 13 filings · 17 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-31P, purchase reported on Form 416,000$419.5K2022-01-04
2023-03-03S, sale reported on Form 43,587$315.5K2023-03-06
2023-03-07S, sale reported on Form 4622$52.7K2023-03-08
2023-05-15S, sale reported on Form 48,867$752.5K2023-05-17
2023-05-15S, sale reported on Form 412,440$1.0M2023-05-17
2023-05-15S, sale reported on Form 4200$17.1K2023-05-17
2023-05-16S, sale reported on Form 4625$50.6K2023-05-17
2023-06-12S, sale reported on Form 44,711$469.3K2023-06-14
2023-06-13S, sale reported on Form 49,157$925.3K2023-06-14
2023-06-13S, sale reported on Form 49,326$930.3K2023-06-14
2023-06-13S, sale reported on Form 4250$26.4K2023-06-14
2023-06-13S, sale reported on Form 416,163$1.6M2023-06-14
2023-06-13S, sale reported on Form 43,643$374.2K2023-06-14
2023-06-13S, sale reported on Form 425,530$2.7M2023-06-14
2023-06-13S, sale reported on Form 414,016$1.5M2023-06-14
2023-07-28S, sale reported on Form 475,000$12.3M2023-08-01
2023-08-16S, sale reported on Form 41,755$295.6K2023-08-17

Summit Therapeutics Inc. (SMMT)

COO and CFO, Director · 9 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-10-13P, purchase reported on Form 42,976,190$5.0M2023-10-16
2026-06-04P, purchase reported on Form 425,000$360.8K2026-06-04
2026-06-04P, purchase reported on Form 425,000$361.5K2026-06-04

Pulse Biosciences, INC. (PLSE)

Director · 6 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1569769) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms